MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$1,266M
Free Cash flow
$7,295M
Unit: Million (M) dollars
Positive Cash Flow Breakdown
Net earnings
Decrease in accounts payable and...
Depreciation and amortization of...
Others
Negative Cash Flow Breakdown
Repayment of short-term debt, ne...
Dividends to shareholders
Increase in accounts receivable
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-28
2026-03-29
2025-12-28
2025-09-28
Net earnings
5,534
5,235
5,116
5,152
Depreciation and amortization of property and intangibles
1,959
2,004
2,011
1,777
Stock based compensation
458
300
309
347
Asset write-downs
184
36
81
93
Charges for acquired in-process research and development
-
-
109
-
(gain) on separation of kenvue
-
-
0
-
Charges for acquired in-process research and development assets
0
-107
-
17
Net loss/(gain) on sale of assets/businesses
55
-12
132
57
Deferred tax provision
-479
159
-3,677
2,218
Credit losses and accounts receivable allowances
-4
-8
5
-9
Increase in accounts receivable
1,352
595
-391
-111
Increase in inventories
571
431
46
748
Decrease in accounts payable and accrued liabilities
2,964
-3,920
1,266
1,997
Decrease/(increase) in other current and non-current assets
-950
-349
-1,486
1,459
Decrease in other current and non-current liabilities
-972
-629
499
-270
Net cash flows from operating activities
8,616
2,514
7,309
9,169
Additions to property, plant and equipment
1,321
1,049
1,837
1,157
Proceeds from the disposal of assets/businesses, net (note 10)
63
29
312
76
Acquisitions, net of cash acquired (note 10)
263
-
3,082
1
Acquired in-process research and development/related milestones (note 18)
-
-
385
-
Acquired in-process research and development assets / related milestones (note 10)
0
-385
-
16
Purchases of investments
155
144
243
246
Sales of investments
159
209
219
489
Credit support agreements activity, net
546
-31
209
346
Other (including capitalized licenses and milestones)
139
54
63
33
Net cash used for investing activities
-1,110
-1,040
-4,485
-542
Dividends to shareholders
3,227
3,131
3,131
3,132
Repurchase of common stock
221
4,028
1,924
1,902
Proceeds from short-term debt, net
707
12,439
3,913
1,324
Repayment of short-term debt, net
6,454
3,223
1,806
5,466
Proceeds from long-term debt, net of issuance costs
0
0
0
0
Repayment of long-term debt
1
2,002
2
1,001
Proceeds from the exercise of stock options/employee withholding tax on stock awards, net
359
1,172
1,587
1,274
Credit support agreements activity, net
60
-109
20
25
Settlement of convertible debt acquired from shockwave
-
-
0
0
Proceeds of short and long-term debt, net of issuance cost, related to the debt that transferred to kenvue at separation
-
-
0
-
Proceeds from kenvue initial public offering
-
-
0
-
Cash transferred to kenvue at separation
-
-
0
-
Other
0
-588
-26
-49
Net cash (used for) from financing activities
-8,777
530
-1,369
-8,927
Effect of exchange rate changes on cash and cash equivalents
5
-25
23
-46
Increase in cash and cash equivalents
-1,266
1,979
1,478
-346
Cash and cash equivalents, beginning of period
18,577
38,474
-
38,474
Cash and cash equivalents, end of period
20,422
21,688
-
18,231
Page 1
Unit: Million (M) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net earnings
$5,534M
(-0.05%↓ Y/Y)
Decrease in accounts
payable and accrued...
$2,964M
(139.03%↑ Y/Y)
Depreciation and
amortization of property and...
$1,959M
(0.82%↑ Y/Y)
Decrease/(increase) in other current
and non-current...
-$950M
(-119.48%↓ Y/Y)
Stock based
compensation
$458M
(11.71%↑ Y/Y)
Asset write-downs
$184M
Net cash flows from
operating activities
$8,616M
(122.18%↑ Y/Y)
Effect of exchange rate
changes on cash and cash...
$5M
(-96.75%↓ Y/Y)
Canceled cashflow
$3,433M
Increase in cash and cash
equivalents
-$1,266M
(93.64%↑ Y/Y)
Canceled cashflow
$8,621M
Proceeds from short-term
debt, net
$707M
(25.13%↑ Y/Y)
Proceeds from the
exercise of stock...
$359M
(235.51%↑ Y/Y)
Credit support
agreements activity, net
$60M
(122.39%↑ Y/Y)
Credit support
agreements activity, net
$546M
(118.32%↑ Y/Y)
Sales of investments
$159M
(-78.37%↓ Y/Y)
Proceeds from the
disposal of...
$63M
(18.87%↑ Y/Y)
Increase in accounts
receivable
$1,352M
(-0.37%↓ Y/Y)
Decrease in other current
and non-current...
-$972M
(-266.72%↓ Y/Y)
Increase in inventories
$571M
(11.96%↑ Y/Y)
Deferred tax provision
-$479M
(-158.06%↓ Y/Y)
Net loss/(gain) on
sale of...
$55M
(5600.00%↑ Y/Y)
Credit losses and
accounts receivable...
-$4M
(-157.14%↓ Y/Y)
Net cash (used for)
from financing...
-$8,777M
(-54.93%↓ Y/Y)
Canceled cashflow
$1,126M
Net cash used for
investing activities
-$1,110M
(93.92%↑ Y/Y)
Canceled cashflow
$768M
Repayment of short-term
debt, net
$6,454M
(119.67%↑ Y/Y)
Dividends to shareholders
$3,227M
(3.13%↑ Y/Y)
Repurchase of common stock
$221M
Repayment of long-term
debt
$1M
(-66.67%↓ Y/Y)
Additions to property,
plant and equipment
$1,321M
(26.65%↑ Y/Y)
Acquisitions, net of cash
acquired (note 10)
$263M
(-98.18%↓ Y/Y)
Purchases of investments
$155M
(-13.89%↓ Y/Y)
Other (including
capitalized licenses and...
$139M
(286.11%↑ Y/Y)
Buy us a coffee
JNJ_BIG_BIG copy-svg
JOHNSON & JOHNSON (JNJ)
JNJ_BIG_BIG copy-svg
JOHNSON & JOHNSON (JNJ)
Show more